Heterogeneity of Residual Disease After Neoadjuvant Systemic Therapy in Breast Cancer

94

Heterogeneity of Residual Disease After Neoadjuvant Systemic Therapy in Breast Cancer

Tags:

Previous Article

Defining microglial-synapse interactions

Clinical sequelae of gut microbiome development and disruption in hospitalized p...

Related Posts

Dietary medium-chain triacylglycerols in metabolic regulation

Dietary medium-chain triacylglycerols in metabolic regu...

127

Topological turning points across the human lifespan

Topological turning points across the human lifespan

32

Snake venom protection by a cocktail of varespladib and broadly neutralizing human antibodies

Snake venom protection by a cocktail of varespladib and...

86